Cell Therapy
Cross-source consensus on Cell Therapy from 1 sources and 4 claims.
1 sources · 4 claims
Benefits
Dosage & preparation
Risks & contraindications
Evidence quality
Highlighted claims
- The recommendation for cell therapy remained weak due to moderate statistical heterogeneity, risk of bias, and imprecision. — Advanced therapeutic approaches for inherited retinal diseases: an umbrella review
- Cell therapy improved visual acuity in a review of 18 clinical trials involving 224 eyes across AMD, SMD, and RP. — Advanced therapeutic approaches for inherited retinal diseases: an umbrella review
- Moderate-quality evidence for cell therapy showed a visual acuity improvement with a mean difference of +0.25 (95% CI 0.15 to 0.45) on the logMAR scale. — Advanced therapeutic approaches for inherited retinal diseases: an umbrella review
- Safety evidence for cell therapy was moderate quality, with low heterogeneity for adverse events suggesting low risk. — Advanced therapeutic approaches for inherited retinal diseases: an umbrella review